XML 44 R25.htm IDEA: XBRL DOCUMENT v2.4.1.9
Segment Information
 12 Months Ended
Sep. 30, 2014
Segment Information [Abstract]  
Segment Information

17.Segment Information

The Company changed the presentation of its reporting segments to separately disclose certain ‘corporate expenses’ that had previously been reported within the Radiation Measurement segment.  As a result, the current segment disclosures have been retrospectively adjusted to reflect three reporting segments; Radiation Measurement, Medical Physics and Medical Products and one functional group;  Corporate. The factors for determining the reportable segments reflect specific markets and the products and services offered combined with the nature of the individual business traits, as well as key financial information reviewed by management.

 

The Radiation Measurement segment provides analytical services to determine occupational and environmental radiation exposure. These services are provided internationally primarily to hospitals, medical and dental offices, universities, national laboratories, and nuclear facilities. Radiation Measurement activities include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from customers, and the analysis and reporting of exposure findings. In addition to providing analytical services, the Radiation Measurement segment sells dosimetry detectors and reading equipment.

 

The Medical Physics segment provides therapeutic and imaging physics services to domestic hospitals and radiation therapy centers. Service offerings include clinical physics support, equipment commissioning, accreditation support and imaging equipment testing. These professional services are provided to customers on-site by skilled physicists.

 

The Medical Products segment provides medical consumable accessories used in radiology, radiation therapy, and image guided surgery procedures. Medical products range from consumables used with MRI, CT, and mammography technologies to highly engineered passive reflective markers used during image guided surgery procedures.

 

The Company primarily evaluates performance of the individual segments based upon, among other metrics, segment operating income or loss. Segment operating income or loss is segment revenues less segment cost of sales and segment selling, general and administrative expenses. Corporate expenses for shared functions, including corporate management, corporate finance and human resources, are recognized in the Corporate functional group. In addition, acquisition and reorganization costs are not allocated to the segments. Information about net other income, including interest income and expense, and income taxes is not provided at the segment level. As the Company’s business model evolves in increased complexity, management may determine it necessary to change this reporting practice to reflect any appropriate allocations.

 

The following tables summarize financial information for each reportable segment for the years ended September 30:

 

 

 

 

 

 

 

 

 

 

(Dollars in Thousands)

 

2014

 

2013
(As Restated)

 

2012

Revenues by segment:

 

 

 

 

 

 

 

 

 

Radiation Measurement

 

$
113,556 

 

$
109,326 

 

$
107,624 

Medical Physics

 

 
32,213 

 

 
30,859 

 

 
30,937 

Medical Products

 

 
9,293 

 

 
9,505 

 

 
13,541 

Consolidated revenues

 

$
155,062 

 

$
149,690 

 

$
152,102 

 

 

 

 

 

 

 

 

 

 

 

 

2014

 

2013
(As Restated)

 

2012

Operating income (loss) by segment:

 

 

 

 

 

 

 

 

 

Radiation Measurement

 

$
38,231 

 

$
38,682 

 

$
43,381 

Medical Physics

 

 
1,827 

 

 
3,499 

 

 
1,329 

Medical Products (1)

 

 
(62,572)

 

 
(21,778)

 

 
5,097 

Corporate

 

 
(17,473)

 

 
(17,014)

 

 
(22,100)

Consolidated operating (loss) income

 

$
(39,987)

 

$
3,389 

 

$
27,707 

 

 

 

 

 

 

 

 

 

 

 

 

2014

 

2013
(As Restated)

 

2012

Depreciation and amortization by segment:

 

 

 

 

 

 

 

 

 

Radiation Measurement

 

$
10,250 

 

$
11,357 

 

$
8,507 

Medical Physics

 

 
1,085 

 

 
1,185 

 

 
1,419 

Medical Products

 

 
2,580 

 

 
2,509 

 

 
2,035 

Consolidated depreciation and amortization

 

$
13,915 

 

$
15,051 

 

$
11,961 

 

(1)Includes goodwill and intangibles asset impairment charge of $62,188 and $22,700 in fiscal 2014 and 2013, respectively.

 

 

 

 

 

 

 

 

(Dollars in Thousands)

 

2014

 

2013
(As Restated)

Segment assets:

 

 

 

 

 

 

Radiation Measurement

 

$
148,151 

 

$
168,592 

Medical Physics

 

 
38,851 

 

 
41,740 

Medical Products

 

 
48,164 

 

 
81,925 

Eliminations

 

 
(18,580)

 

 
(17,551)

Consolidated assets

 

$
216,586 

 

$
274,706